VictoryShares US EQ Income Enhanced Volatility Wtd ETF
VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Peers
See (CDC) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management - Income Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CDC | $62.98 | +0.27% | 729.7M | 16.97 | $3.71 | +3.31% |
| PIMIX | $10.62 | +0.19% | 180.7B | N/A | N/A | N/A |
| PONAX | $10.62 | +0.19% | 180.7B | N/A | N/A | N/A |
| PONPX | $10.62 | +0.19% | 180.7B | N/A | N/A | N/A |
| AMECX | $26.10 | +0.12% | 127.4B | 18.95 | $1.38 | +3.83% |
| RIDGX | $26.12 | +0.11% | 127.4B | 18.95 | $1.38 | N/A |
| IFAFX | $26.00 | +0.12% | 127.4B | 18.94 | $1.37 | +3.78% |
| CWIAX | $67.60 | -0.04% | 122.8B | 22.10 | $3.06 | N/A |
| RWICX | $67.30 | -0.04% | 122.8B | 22.09 | $3.05 | N/A |
| CWGIX | $67.92 | -0.04% | 122.8B | 22.10 | $3.07 | N/A |
Stock Comparison
CDC vs PIMIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PIMIX has a market cap of 180.7B. Regarding current trading prices, CDC is priced at $62.98, while PIMIX trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PIMIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PIMIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PIMIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PONAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PONAX has a market cap of 180.7B. Regarding current trading prices, CDC is priced at $62.98, while PONAX trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PONAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PONAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PONAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PONPX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PONPX has a market cap of 180.7B. Regarding current trading prices, CDC is priced at $62.98, while PONPX trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PONPX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PONPX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PONPX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs AMECX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, AMECX has a market cap of 127.4B. Regarding current trading prices, CDC is priced at $62.98, while AMECX trades at $26.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas AMECX's P/E ratio is 18.95. In terms of profitability, CDC's ROE is +0.00%, compared to AMECX's ROE of +0.09%. Regarding short-term risk, CDC is more volatile compared to AMECX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs RIDGX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, RIDGX has a market cap of 127.4B. Regarding current trading prices, CDC is priced at $62.98, while RIDGX trades at $26.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas RIDGX's P/E ratio is 18.95. In terms of profitability, CDC's ROE is +0.00%, compared to RIDGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RIDGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs IFAFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, IFAFX has a market cap of 127.4B. Regarding current trading prices, CDC is priced at $62.98, while IFAFX trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas IFAFX's P/E ratio is 18.94. In terms of profitability, CDC's ROE is +0.00%, compared to IFAFX's ROE of +0.09%. Regarding short-term risk, CDC is more volatile compared to IFAFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CWIAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CWIAX has a market cap of 122.8B. Regarding current trading prices, CDC is priced at $62.98, while CWIAX trades at $67.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CWIAX's P/E ratio is 22.10. In terms of profitability, CDC's ROE is +0.00%, compared to CWIAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CWIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs RWICX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, RWICX has a market cap of 122.8B. Regarding current trading prices, CDC is priced at $62.98, while RWICX trades at $67.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas RWICX's P/E ratio is 22.09. In terms of profitability, CDC's ROE is +0.00%, compared to RWICX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RWICX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CWGIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CWGIX has a market cap of 122.8B. Regarding current trading prices, CDC is priced at $62.98, while CWGIX trades at $67.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CWGIX's P/E ratio is 22.10. In terms of profitability, CDC's ROE is +0.00%, compared to CWGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CWGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CWGFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CWGFX has a market cap of 122.8B. Regarding current trading prices, CDC is priced at $62.98, while CWGFX trades at $67.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CWGFX's P/E ratio is 22.10. In terms of profitability, CDC's ROE is +0.00%, compared to CWGFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CWGFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs RIRGX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, RIRGX has a market cap of 109.3B. Regarding current trading prices, CDC is priced at $62.98, while RIRGX trades at $74.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas RIRGX's P/E ratio is 18.88. In terms of profitability, CDC's ROE is +0.00%, compared to RIRGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RIRGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CIBFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CIBFX has a market cap of 109.3B. Regarding current trading prices, CDC is priced at $62.98, while CIBFX trades at $74.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CIBFX's P/E ratio is 18.87. In terms of profitability, CDC's ROE is +0.00%, compared to CIBFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CIBFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CAIBX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CAIBX has a market cap of 109.3B. Regarding current trading prices, CDC is priced at $62.98, while CAIBX trades at $74.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CAIBX's P/E ratio is 18.87. In terms of profitability, CDC's ROE is +0.00%, compared to CAIBX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CAIBX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CIRAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CIRAX has a market cap of 109.3B. Regarding current trading prices, CDC is priced at $62.98, while CIRAX trades at $74.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CIRAX's P/E ratio is 18.87. In terms of profitability, CDC's ROE is +0.00%, compared to CIRAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CIRAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs DODIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, DODIX has a market cap of 94.4B. Regarding current trading prices, CDC is priced at $62.98, while DODIX trades at $12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas DODIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DODIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to DODIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FKINX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FKINX has a market cap of 80.6B. Regarding current trading prices, CDC is priced at $62.98, while FKINX trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FKINX's P/E ratio is 17.32. In terms of profitability, CDC's ROE is +0.00%, compared to FKINX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FKINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FNCFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FNCFX has a market cap of 80B. Regarding current trading prices, CDC is priced at $62.98, while FNCFX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FNCFX's P/E ratio is 17.25. In terms of profitability, CDC's ROE is +0.00%, compared to FNCFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FNCFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VEIPX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VEIPX has a market cap of 55.9B. Regarding current trading prices, CDC is priced at $62.98, while VEIPX trades at $43.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VEIPX's P/E ratio is 14.60. In terms of profitability, CDC's ROE is +0.00%, compared to VEIPX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VEIPX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VEIRX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VEIRX has a market cap of 55.9B. Regarding current trading prices, CDC is priced at $62.98, while VEIRX trades at $90.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VEIRX's P/E ratio is 14.60. In terms of profitability, CDC's ROE is +0.00%, compared to VEIRX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VEIRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VWIAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VWIAX has a market cap of 48B. Regarding current trading prices, CDC is priced at $62.98, while VWIAX trades at $61.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VWIAX's P/E ratio is 15.68. In terms of profitability, CDC's ROE is +0.00%, compared to VWIAX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VWIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VWINX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VWINX has a market cap of 48B. Regarding current trading prices, CDC is priced at $62.98, while VWINX trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VWINX's P/E ratio is 15.68. In terms of profitability, CDC's ROE is +0.00%, compared to VWINX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VWINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs LDLVX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, LDLVX has a market cap of 42.2B. Regarding current trading prices, CDC is priced at $62.98, while LDLVX trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas LDLVX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to LDLVX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to LDLVX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs LLDYX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, LLDYX has a market cap of 42.2B. Regarding current trading prices, CDC is priced at $62.98, while LLDYX trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas LLDYX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to LLDYX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to LLDYX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs OIEJX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, OIEJX has a market cap of 41.9B. Regarding current trading prices, CDC is priced at $62.98, while OIEJX trades at $24.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas OIEJX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to OIEJX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to OIEJX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HLIEX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HLIEX has a market cap of 41.9B. Regarding current trading prices, CDC is priced at $62.98, while HLIEX trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HLIEX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HLIEX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HLIEX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JEPI Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JEPI has a market cap of 38.6B. Regarding current trading prices, CDC is priced at $62.98, while JEPI trades at $55.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JEPI's P/E ratio is 24.52. In terms of profitability, CDC's ROE is +0.00%, compared to JEPI's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to JEPI. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VTINX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VTINX has a market cap of 34.8B. Regarding current trading prices, CDC is priced at $62.98, while VTINX trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VTINX's P/E ratio is 19.47. In terms of profitability, CDC's ROE is +0.00%, compared to VTINX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to VTINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JPST Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JPST has a market cap of 31B. Regarding current trading prices, CDC is priced at $62.98, while JPST trades at $50.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JPST's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JPST's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to JPST. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JEPQ Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JEPQ has a market cap of 24B. Regarding current trading prices, CDC is priced at $62.98, while JEPQ trades at $52.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JEPQ's P/E ratio is 30.37. In terms of profitability, CDC's ROE is +0.00%, compared to JEPQ's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to JEPQ. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs AHTFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, AHTFX has a market cap of 23.4B. Regarding current trading prices, CDC is priced at $62.98, while AHTFX trades at $9.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas AHTFX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to AHTFX's ROE of -0.09%. Regarding short-term risk, CDC is more volatile compared to AHTFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PRFDX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PRFDX has a market cap of 23B. Regarding current trading prices, CDC is priced at $62.98, while PRFDX trades at $35.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PRFDX's P/E ratio is 18.81. In terms of profitability, CDC's ROE is +0.00%, compared to PRFDX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PRFDX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIBIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIBIX has a market cap of 20.2B. Regarding current trading prices, CDC is priced at $62.98, while TIBIX trades at $29.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIBIX's P/E ratio is 3.55. In terms of profitability, CDC's ROE is +0.00%, compared to TIBIX's ROE of +0.01%. Regarding short-term risk, CDC is more volatile compared to TIBIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIBMX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIBMX has a market cap of 20.2B. Regarding current trading prices, CDC is priced at $62.98, while TIBMX trades at $29.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIBMX's P/E ratio is 3.55. In terms of profitability, CDC's ROE is +0.00%, compared to TIBMX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBMX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIBGX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIBGX has a market cap of 20.1B. Regarding current trading prices, CDC is priced at $62.98, while TIBGX trades at $29.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIBGX's P/E ratio is 3.53. In terms of profitability, CDC's ROE is +0.00%, compared to TIBGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIBAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIBAX has a market cap of 20B. Regarding current trading prices, CDC is priced at $62.98, while TIBAX trades at $29.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIBAX's P/E ratio is 3.52. In terms of profitability, CDC's ROE is +0.00%, compared to TIBAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIBRX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIBRX has a market cap of 20B. Regarding current trading prices, CDC is priced at $62.98, while TIBRX trades at $29.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIBRX's P/E ratio is 3.52. In terms of profitability, CDC's ROE is +0.00%, compared to TIBRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIBCX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIBCX has a market cap of 20B. Regarding current trading prices, CDC is priced at $62.98, while TIBCX trades at $29.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIBCX's P/E ratio is 3.52. In terms of profitability, CDC's ROE is +0.00%, compared to TIBCX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIBCX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs GAIFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, GAIFX has a market cap of 18.5B. Regarding current trading prices, CDC is priced at $62.98, while GAIFX trades at $19.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas GAIFX's P/E ratio is 23.36. In terms of profitability, CDC's ROE is +0.00%, compared to GAIFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to GAIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs MIAWX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, MIAWX has a market cap of 17.4B. Regarding current trading prices, CDC is priced at $62.98, while MIAWX trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas MIAWX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to MIAWX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to MIAWX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs COSIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, COSIX has a market cap of 16.4B. Regarding current trading prices, CDC is priced at $62.98, while COSIX trades at $21.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas COSIX's P/E ratio is 24.85. In terms of profitability, CDC's ROE is +0.00%, compared to COSIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to COSIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs IGIFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, IGIFX has a market cap of 16B. Regarding current trading prices, CDC is priced at $62.98, while IGIFX trades at $41.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas IGIFX's P/E ratio is 16.87. In terms of profitability, CDC's ROE is +0.00%, compared to IGIFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to IGIFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PRCIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PRCIX has a market cap of 16B. Regarding current trading prices, CDC is priced at $62.98, while PRCIX trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PRCIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PRCIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PRCIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PRXEX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PRXEX has a market cap of 16B. Regarding current trading prices, CDC is priced at $62.98, while PRXEX trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PRXEX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PRXEX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PRXEX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VGIAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VGIAX has a market cap of 14.7B. Regarding current trading prices, CDC is priced at $62.98, while VGIAX trades at $103.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VGIAX's P/E ratio is 21.46. In terms of profitability, CDC's ROE is +0.00%, compared to VGIAX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VGIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs VQNPX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, VQNPX has a market cap of 14.7B. Regarding current trading prices, CDC is priced at $62.98, while VQNPX trades at $63.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas VQNPX's P/E ratio is 21.46. In terms of profitability, CDC's ROE is +0.00%, compared to VQNPX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to VQNPX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FFRHX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FFRHX has a market cap of 14.4B. Regarding current trading prices, CDC is priced at $62.98, while FFRHX trades at $9.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FFRHX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FFRHX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FFRHX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FADMX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FADMX has a market cap of 14.3B. Regarding current trading prices, CDC is priced at $62.98, while FADMX trades at $11.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FADMX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FADMX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FADMX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs BLPFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, BLPFX has a market cap of 14.3B. Regarding current trading prices, CDC is priced at $62.98, while BLPFX trades at $18.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas BLPFX's P/E ratio is 22.61. In terms of profitability, CDC's ROE is +0.00%, compared to BLPFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to BLPFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FAGIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FAGIX has a market cap of 13.1B. Regarding current trading prices, CDC is priced at $62.98, while FAGIX trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FAGIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FAGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FAGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FLTMX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FLTMX has a market cap of 12.7B. Regarding current trading prices, CDC is priced at $62.98, while FLTMX trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FLTMX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FLTMX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FLTMX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs ABHFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, ABHFX has a market cap of 12.5B. Regarding current trading prices, CDC is priced at $62.98, while ABHFX trades at $14.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas ABHFX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to ABHFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to ABHFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PFIAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PFIAX has a market cap of 12.5B. Regarding current trading prices, CDC is priced at $62.98, while PFIAX trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PFIAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PFIAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PFIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PFIIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PFIIX has a market cap of 12.5B. Regarding current trading prices, CDC is priced at $62.98, while PFIIX trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PFIIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to PFIIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PFIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs ACEIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, ACEIX has a market cap of 11.7B. Regarding current trading prices, CDC is priced at $62.98, while ACEIX trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas ACEIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to ACEIX's ROE of -0.30%. Regarding short-term risk, CDC is more volatile compared to ACEIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HBLTX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HBLTX has a market cap of 11.7B. Regarding current trading prices, CDC is priced at $62.98, while HBLTX trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HBLTX's P/E ratio is 18.92. In terms of profitability, CDC's ROE is +0.00%, compared to HBLTX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HBLTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HBLRX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HBLRX has a market cap of 11.7B. Regarding current trading prices, CDC is priced at $62.98, while HBLRX trades at $14.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HBLRX's P/E ratio is 18.91. In terms of profitability, CDC's ROE is +0.00%, compared to HBLRX's ROE of -0.12%. Regarding short-term risk, CDC is more volatile compared to HBLRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HBLVX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HBLVX has a market cap of 11.7B. Regarding current trading prices, CDC is priced at $62.98, while HBLVX trades at $14.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HBLVX's P/E ratio is 18.93. In terms of profitability, CDC's ROE is +0.00%, compared to HBLVX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HBLVX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FGRIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FGRIX has a market cap of 11.1B. Regarding current trading prices, CDC is priced at $62.98, while FGRIX trades at $64.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FGRIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FGRIX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FGRIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JSOAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JSOAX has a market cap of 10.4B. Regarding current trading prices, CDC is priced at $62.98, while JSOAX trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JSOAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JSOAX's ROE of +0.02%. Regarding short-term risk, CDC is more volatile compared to JSOAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TSIIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TSIIX has a market cap of 9.5B. Regarding current trading prices, CDC is priced at $62.98, while TSIIX trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TSIIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to TSIIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TSIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs ESIIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, ESIIX has a market cap of 9.3B. Regarding current trading prices, CDC is priced at $62.98, while ESIIX trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas ESIIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to ESIIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to ESIIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FEQIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FEQIX has a market cap of 8.4B. Regarding current trading prices, CDC is priced at $62.98, while FEQIX trades at $77.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FEQIX's P/E ratio is 18.02. In terms of profitability, CDC's ROE is +0.00%, compared to FEQIX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FEQIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PQIAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PQIAX has a market cap of 8.2B. Regarding current trading prices, CDC is priced at $62.98, while PQIAX trades at $39.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PQIAX's P/E ratio is 19.36. In terms of profitability, CDC's ROE is +0.00%, compared to PQIAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to PQIAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs INPFX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, INPFX has a market cap of 8.1B. Regarding current trading prices, CDC is priced at $62.98, while INPFX trades at $13.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas INPFX's P/E ratio is 21.42. In terms of profitability, CDC's ROE is +0.00%, compared to INPFX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to INPFX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FZOLX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FZOLX has a market cap of 7.8B. Regarding current trading prices, CDC is priced at $62.98, while FZOLX trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FZOLX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FZOLX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to FZOLX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs CPXAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, CPXAX has a market cap of 7.6B. Regarding current trading prices, CDC is priced at $62.98, while CPXAX trades at $12.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas CPXAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to CPXAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to CPXAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs PDI Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, PDI has a market cap of 7.1B. Regarding current trading prices, CDC is priced at $62.98, while PDI trades at $18.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas PDI's P/E ratio is 8.50. In terms of profitability, CDC's ROE is +0.00%, compared to PDI's ROE of +0.12%. Regarding short-term risk, CDC is more volatile compared to PDI. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JADGX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JADGX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JADGX trades at $71.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JADGX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JADGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JADGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JAGIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JAGIX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JAGIX trades at $71.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JAGIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JAGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JAGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JGICX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JGICX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JGICX trades at $69.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JGICX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JGICX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JGICX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JDNAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JDNAX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JDNAX trades at $71.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JDNAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JDNAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JDNAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JDNRX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JDNRX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JDNRX trades at $70.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JDNRX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JDNRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JDNRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JDNNX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JDNNX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JDNNX trades at $71.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JDNNX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JDNNX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JDNNX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JGINX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JGINX has a market cap of 6.9B. Regarding current trading prices, CDC is priced at $62.98, while JGINX trades at $71.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JGINX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JGINX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JGINX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TWEIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TWEIX has a market cap of 6.7B. Regarding current trading prices, CDC is priced at $62.98, while TWEIX trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TWEIX's P/E ratio is 19.12. In terms of profitability, CDC's ROE is +0.00%, compared to TWEIX's ROE of +0.35%. Regarding short-term risk, CDC is more volatile compared to TWEIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs AEUDX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, AEUDX has a market cap of 6.7B. Regarding current trading prices, CDC is priced at $62.98, while AEUDX trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas AEUDX's P/E ratio is 19.15. In terms of profitability, CDC's ROE is +0.00%, compared to AEUDX's ROE of +0.35%. Regarding short-term risk, CDC is more volatile compared to AEUDX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs DFCF Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, DFCF has a market cap of 6.6B. Regarding current trading prices, CDC is priced at $62.98, while DFCF trades at $41.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas DFCF's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DFCF's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to DFCF. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TGIHX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TGIHX has a market cap of 6.4B. Regarding current trading prices, CDC is priced at $62.98, while TGIHX trades at $14.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TGIHX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to TGIHX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TGIHX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TRGIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TRGIX has a market cap of 6.4B. Regarding current trading prices, CDC is priced at $62.98, while TRGIX trades at $15.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TRGIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to TRGIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TRGIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs TIIRX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, TIIRX has a market cap of 6.4B. Regarding current trading prices, CDC is priced at $62.98, while TIIRX trades at $26.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas TIIRX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to TIIRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to TIIRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs DLFNX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, DLFNX has a market cap of 6.4B. Regarding current trading prices, CDC is priced at $62.98, while DLFNX trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas DLFNX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DLFNX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to DLFNX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FCONX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FCONX has a market cap of 6.2B. Regarding current trading prices, CDC is priced at $62.98, while FCONX trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FCONX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FCONX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FCONX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JEPAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JEPAX has a market cap of 6.2B. Regarding current trading prices, CDC is priced at $62.98, while JEPAX trades at $13.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JEPAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JEPAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JEPAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs NSTLX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, NSTLX has a market cap of 6.1B. Regarding current trading prices, CDC is priced at $62.98, while NSTLX trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas NSTLX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to NSTLX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to NSTLX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs OAKBX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, OAKBX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while OAKBX trades at $36.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas OAKBX's P/E ratio is 18.03. In terms of profitability, CDC's ROE is +0.00%, compared to OAKBX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to OAKBX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HFQTX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HFQTX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while HFQTX trades at $6.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HFQTX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQTX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HFQSX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HFQSX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while HFQSX trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HFQSX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQSX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQSX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HFQCX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HFQCX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while HFQCX trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HFQCX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQCX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQCX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HFQRX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HFQRX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while HFQRX trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HFQRX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQRX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQRX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HFQIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HFQIX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while HFQIX trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HFQIX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs HFQAX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, HFQAX has a market cap of 6B. Regarding current trading prices, CDC is priced at $62.98, while HFQAX trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas HFQAX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to HFQAX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to HFQAX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs DFIGX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, DFIGX has a market cap of 5.9B. Regarding current trading prices, CDC is priced at $62.98, while DFIGX trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas DFIGX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to DFIGX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to DFIGX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs RPSIX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, RPSIX has a market cap of 5.9B. Regarding current trading prices, CDC is priced at $62.98, while RPSIX trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas RPSIX's P/E ratio is 18.93. In terms of profitability, CDC's ROE is +0.00%, compared to RPSIX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to RPSIX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FEQTX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FEQTX has a market cap of 5.5B. Regarding current trading prices, CDC is priced at $62.98, while FEQTX trades at $28.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FEQTX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FEQTX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FEQTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs FETKX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, FETKX has a market cap of 5.5B. Regarding current trading prices, CDC is priced at $62.98, while FETKX trades at $28.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas FETKX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to FETKX's ROE of +0.00%. Regarding short-term risk, CDC is more volatile compared to FETKX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JMTNX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JMTNX has a market cap of 5.3B. Regarding current trading prices, CDC is priced at $62.98, while JMTNX trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JMTNX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMTNX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMTNX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JMUCX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JMUCX has a market cap of 5.3B. Regarding current trading prices, CDC is priced at $62.98, while JMUCX trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JMUCX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUCX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUCX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JMUTX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JMUTX has a market cap of 5.3B. Regarding current trading prices, CDC is priced at $62.98, while JMUTX trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JMUTX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUTX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUTX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.
CDC vs JMUSX Comparison
CDC plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CDC stands at 729.7M. In comparison, JMUSX has a market cap of 5.3B. Regarding current trading prices, CDC is priced at $62.98, while JMUSX trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CDC currently has a P/E ratio of 16.97, whereas JMUSX's P/E ratio is N/A. In terms of profitability, CDC's ROE is +0.00%, compared to JMUSX's ROE of N/A. Regarding short-term risk, CDC is more volatile compared to JMUSX. This indicates potentially higher risk in terms of short-term price fluctuations for CDC.